Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
GSK-Financed Study Shows Global Decline in Adult Immunization Rates
Despite the widespread attention given to COVID-19 vaccines in recent times, there has been a significant decline in the uptake ...
Eisai Unveils Lecanemab’s Alzheimer’s Breakthrough at AAIC 2023
Source – Eisai July 20, 2023 Biogen revealed the results of a comprehensive analysis of the Phase III Clarity AD ...
Roche’s Vabysmo Shows Promising Vision Loss Improvement at ASRS
Source – Roche On July 20, Roche announced that they will be presenting data from their ophthalmology portfolio in 25 ...
Gilead’s IAS 2023: Advancing Health Equity and HIV Pipeline Progress
Source – Gilead On July 20, a leading force in HIV innovation, announced its significant participation in the 12th International ...
Sandoz Plans Biosimilar Technical Development Centre in Slovenia for Future Pipeline Expansion
Source – Novartis July 20, 2023, Sandoz, a renowned global leader in generic and biosimilar medicines, has disclosed a substantial ...
Pfizer Unveils Promising GBS Maternal Vaccine in New England Journal of Medicine
Source – Pfizer On July 19, Pfizer released promising data from a Phase II study of their GBS6 vaccine candidate, ...
Selinexor Receives Fast Track Designation from FDA for Myelofibrosis Treatment
Source – Karyopharm Therapeutics The FDA has granted fast track designation to selinexor (Xpovio) for the treatment of patients with ...
Cervical Cancer: Frontline SHR-1701 Plus BP102 and Chemo Shows Potent Activity
The combination of the novel bifunctional fusion protein SHR-1701 with bevacizumab (BP102) and platinum-doublet chemotherapy has shown promising results in ...
Lazertinib Beats Gefitinib in Treating EGFR-Mutated NSCLC
In a Phase III study known as LASER301 (NCT04248829) and published in the Journal of Clinical Oncology, lazertinib (formerly YH25448), ...
Rivoceranib Plus Camrelizumab NDA for Unresectable HCC is Accepted by the FDA
Source – Elevar therapeutics On July 17, 2023, The FDA has accepted a New Drug Application (NDA) for rivoceranib, an ...
Positive Effects of Rybrevant Plus Chemotherapy in Early EGFR Exon 20 Insertion NSCLC
Source – Johnson & Johnson The combination of amivantamab-vmjw (Rybrevant) with the chemotherapy doublet carboplatin and pemetrexed has demonstrated a ...
AI predicts the likelihood of birth abnormalities from new medications
Scientists at the Icahn School of Medicine at Mount Sinai in New York have developed an artificial intelligence (AI) algorithm ...
Pfizer and Flagship sign a $7 billion strategic level R&D agreement
Source – Pfizer Pfizer has formed a significant partnership with venture capital firm Flagship Pioneering, worth up to $7 billion, ...
GSK Recalls Nucala in Taiwan Due to Glass Particles – Breaking News!
When it comes to drug packaging, a vial is typically seen as a separate entity from the product it contains. ...
Phreesia Acquires MediFind to Enhance Patient Experience and Outcomes
Phreesia, a software as a service (SaaS) firm specializing in life sciences and healthcare, has announced its acquisition of MediFind, ...
The CDC vaccination committee has scheduled a date in August to consider using Sanofi, Arizona’s Beyfortus RSV antibody
Following its highly anticipated FDA approval on Monday, the respiratory syncytial virus (RSV) antibody developed by Sanofi and AstraZeneca is ...
Johnson & Johnson is the fourth pharmaceutical company to sue the IRA over its medicine price negotiations
Johnson & Johnson has joined the wave of litigation by becoming the fourth major pharmaceutical company to sue the US ...
Maintaining Durable QOL in HER2+ Breast Cancer Patients: Trastuzumab Deruxtecan
Results published in Annals of Oncology indicate that Trastuzumab deruxtecan (T-DXd; Enhertu) showed superior health-related quality-of-life (HRQOL) outcomes compared to ...
At the AAIC, Alnylam presents a long-acting amyloid medication
Source – Alnylam Pharmaceuticals Alnylam has presented promising preliminary clinical results for its new RNA interference candidate, ALN-APP, which targets ...
FDA Approves IND for Selected Advanced Solid Tumors Using ADRX-0706
Source – Adcentrx Therapeutics The FDA has granted clearance to Adventrx Therapeutics’ IND application for ADRX-0706, a promising treatment for ...
Futura’s over-the-counter erectile dysfunction gel is acquired by Haleon
Just a little over a month after receiving FDA approval for the first over-the-counter (OTC) topical therapy for erectile dysfunction ...
Big Health Acquires Limbix, a DTx Developer for Teen Depression
Source – Big Health In a move to further consolidate its position in the digital therapeutics (DTx) sector, Big Health ...
Donanemab Shows Significant Advance in Alzheimerās Treatment
Source – Eli Lilly The full data from Eli Lilly’s TRAILBLAZER-ALZ 2 trial of the amyloid drug donanemab has validated ...
BridgeBio Reports Improved Data for ATTR Cardiomyopathy Drug
Source – BridgeBio BridgeBio is preparing to seek FDA approval for its acoramidis drug to treat transthyretin amyloidosis (ATTR) cardiomyopathy, ...
Catalentās Indiana Facility Faces FDA Observations After Eylea Rejection
Following an unexpected rejection from the FDA for Regeneron’s high-dose Eylea, the FDA disclosed issues related to cleaning and procedures ...
J&Jās Rybrevant Wins in Rare Lung Cancer; Awaits Tagrisso Showdown
Source – Johnson & Johnson In 2021, Johnson & Johnson’s Rybrevant received accelerated approval from the FDA, becoming the first ...
Elevar Therapeutics Announces FDA Acceptance of Rivoceranib-Camrelizumab Combo for Liver Cancer
On July 17, 2023Ā Elevar Therapeutics, a fully integrated biopharmaceutical company focused on improving treatment options for patients with limited ...
Apellisā Syfovre Linked to Eye Inflammation in Geographic Atrophy Patients
Source – Apellis Pharmaceuticals July 17, After receiving FDA approval for the treatment of advanced eye disease geographic atrophy, Apellis ...
FDA has approved Beyfortus as a treatment for RSV illness in newborns
Source – Sanofi On July 17, 2023 Sanofi and AstraZeneca received approval from the US Food and Drug Administration (FDA) ...
Novartis Acquires DTx Pharma to Boost xRNA Platform and Neuroscience Pipeline
Source – Novartis On July 17, Novartis made an announcement regarding its recent acquisition of DTx Pharma, a biotechnology company ...
